Molecular structures of HLA-Specific human NK cell receptors

Chemical Immunology

Volumn 64, Issue , 1996, Pages 88-103

  Cantoni, Claudia ^a   Verdiani, Simonetta ^a   Falco, Michela ^a   Conte, Romana ^a   Biassoni, Roberto ^a  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; LYMPHOCYTE RECEPTOR;

CHEMICAL STRUCTURE; HLA SYSTEM; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

EID: 0029840975     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319335     Document Type: Review

References (70)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-176.
2. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A: Human NK cells: Origin, clonality, specificity and receptors. Adv Immunol 1994,55:341-380.
3. Moretta A, Bittino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA class I molecules in human natural killer cells. Annu Rev Immunol 1996;14.619-648.
4. Lanier LL, Phillips JH: Molecular and cell biology of inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996;17:86-100.
5. Ljunggren H-G, Karre K: In search of the 'missing self. MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
6. Moretta L, Ciccone E, Moretta A, Höglund P, Öhlen C, Kärre K: Allorecognition by NK cells-Nonself or no self? Immunol Today 1992;13:300-306.
7. Burgert HG, Maryanski HL, Kvist S. E3/19K protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc Natl Acad Sci USA 1987;84;1356-1360.
8. Browne H, Smith G, Beck S. Minson T: A complex between the MHC class I homologue encoded by human cytomegalovirus and beta-2-microglobulin. Nature 1990;347:770-772.
9. Del Val M, Hengel H, Hacker H, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH: Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment J Exp Med 1992;176:729-738
10. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern P: Natural history of HLA expression during tumour development. Immunol Today 1993;14.491-499.
11. Garrido F: MHC molecules in normal and neoplastic cells. Int J Cancer 1991;6.1-10.
12. Cabrera T, Ruiz-Cabello F, Garrido F: Biological implications of HLA-DR expression in tumors. Scand J Immunol 1995;41:398-406.
13. Garrido F, Cabrera T, Lopez Nevot MA, Ruiz-Cabello F: HLA class I antigens in human tumours Adv Cancer Res 1995;67:155-195.
14. Yokoyama WM, Seaman WE: The Ly49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex. Annu Rev Immunol 1993;11.613-635
15. Wagtmann N, Biassoni R, Malnati M, Moretta A, Long EO: Purification of a member of the p58 family of putative NK cell surface receptors. Nat Immun 1994;13:195A.
16. Wagtman N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A. Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains Immunity 1995;2:439-449.
17. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL: Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 1995,155:2306-2310.
18. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-408.
19. Held W, Roland J, Raulet DH: Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature 1995;376:355-358.
20. Correa I, Raulet DH. Binding of deverse peptides to MHC class I molecule inhibits target cell lysis by activated natural killer cells. Immunity 1995;2:61-67.
21. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L: The HLA-C specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions J Exp Med 1996,183:645-650.
22. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identifed by direct binding and by functional transfer. Immunity 1995;3:801-809.
23. Lòpez-Cabrera M, Santis AG, Fernandes-Ruiz, Blacher R, Esch F, Sanchez-Mateos P, Sanchez-Madrid F: Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen/CD69. a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 1993;178:537-547.
24. Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR: Molecular characterization of the early activation antigen CD69; A type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol 1993;23:1643-1648
25. Lanier LL, Chang C, Phillips J: Human NKR-P1A, a disulphide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994;153:2417-2427.
26. Aramburu J, Balboa MA, Ramirez A, Silva A, Acevedo A, Sanchez-Madrid F, de Landàzuri MO, Lòpez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-g/d+ T lymphocytes. Inhibition of IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 1990;44:3238-3247.
27. Aramburu J, Balboa MA, Izqierdo M, Lopez-Botet M A novel functional cell surface dimer (Kp43) expressed by natural killer cells and TCR T lymphocytes II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 1991;147:714-721
28. Moretta A, Vitale M, Sivori S, Bottino C, Morelh L, Auguharo R, Barbaresi M, Pende D. Ciccone E, Lopez-Botet M, Moretta L: Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994; 180:545-555.
29. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL: Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995;25:2433-2437.
30. Houchins JP, Yabe T, McSherry C, Bach FH: DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991;173:1017-1020.
31. Dueler M, Offterdinger M, Holzmuller H, Lipp J, Chu CT, Aschauer B, Bach FH, Hofer E: NKG2C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur J Immunol 1995;25:2923-2931.
32. Ciccone E, Pende D, Viale O, Di Donato C, Orengo AM, Biassoni R, Verdiani S, Amoroso A, Moretta A, Moretta L: Involvement of HLA class I alleles in NK cell-specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992,176:963-971.
33. Colonna M, Spies T, Strominger JL, Ciccone E, Moretta A, Moretta L, Pende D, Viale O: Alloantigen recognition by human natural killer cells is associated with HLA-C or a closely linked gene Proc Natl Acad Sci USA 1995;89:7983-7985.
34. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL: HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993;90:12000-12004.
35. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E, Moretta L: Identification of four subsets of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990;172: 1589-1598.
36. Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, Pantaleo G. Moretta L: A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 1990;171:695-714.
37. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Auguharo, R, Barbaresi M, Ciccone E, Moretta L: P58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities J Exp Med 1993;178:597-604.
38. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donato C, Parham P, Moretta L: Amino acid substitutions can influence the NK-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by 'group 2' or 'group 1' NK clones. J Exp Med 1995;182:605-609.
39. Zemmour J, Parhyam P: Distinctive polymorphism at the HLA-C locus: Implication for the expression of HLA-C J Exp Med 1992;176-937-950
40. Zemmour J, Gumperz JE, Hildebrand WH, Ward FE, Marsh SGE, Williams RC, Parham P: The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes. Tissue Antigens 1992;39:249-257.
41. Rajagopalan S, Winter CC, Wagtmann N, Long EO: The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J Immunol 1995;155:4143-4146.
42. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Auguliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors foi HLA-C molecules in human natural killer cells J Exp Med 1995;182:875-884.
43. Weiss A, Littman DR, Signal transduction by lymphocyte antigen receptors. Cell 1994;76.263-274.
44. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996;4:77-85.
45. Emini EA, Hughes JV, Perlow DS, Boger J: Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985;55 836-839.
46. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M: K3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994;180:1235-1242.
47. Gumperz JE, Litwin V, Phillips JA, Lamer LL, Parham P: The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995;181:1133-1144.
48. Litwin V, Gumperz JE, Parham P, Phillips JH, Lanier LL: NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules J Exp Med 1994;180:537-543.
49. Vitale M, Sivori S, Pende D, Auguliaro R, Di Donato C, Amoroso A, Malnati M, Bottino C Moretta L, Moretta A: Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 1996;93:1453-1457.
50. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995;267:1016-1018.
51. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, Accame L, Bottino C, Moretta A, Moretta L: The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors which is characterized by three Ig-like domains and is expressed as a 140 kD disulphide-linked dimer. J Exp Med 1996;184:1-14.
52. Storkus WJ, Salter RD, Alexander J: Class I induced NK resistance in human B cell targets: Identification of non-permissive residues in HLA-A2. Proc Natl Acad Sci USA 1991,88:5989-5993
53. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL: Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and nonself alleles, and influence of the target cell type. J Exp Med 1993;178:1321-1336.
54. Bottino C, Vitale M, Olcese L, Sivori S, Morelli L, Augugliaro R, Ciccone E, Moretta L, Moretta A: The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3ζ chain, FceRIγ chain and the p56Ick kinase. Eur J Immunol 1994;24:2527-2543.
55. Cyster JG, Goodnow CC: Protein tyrosine phosphatase-IC negaqtively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995;2: 13-24.
56. D'Ambrosio D, Hippen KL, Minskoff SA, Mellman I, Pani G, Siminovich KA, Gambier JC: Recruitment and activation of PTPIC in negative regulation of antigen receptor signaling by FcRIIBI. Science 1995;268:293-297.
57. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon T: A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995;269:242-244.
58. Matthews RJ, Bowne DB, Flores E, Thomas ML: Characterization of hematopoietic intracellular protein tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992;12: 2396-2405.
59. Plutzky J, Neel BG, Rosenberg RD: Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 1992,89:1123-1127
60. Shen SH, Bastien L, Postier BI, Chretien P: A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 1991;352:736-739.
61. Yi T, Zhang J, Miura O, Ihle JN: Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: Identification of potential binding sites Blood 1995;85:87-95.
62. Yi TL, Cleveland JL, Ihle JN: Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-P13. Mol Cell Biol 1992;12:836-846.
63. Olcese L, Lang P, Vély F, Cambiaggi A, Marguet D, Bléry M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E: Human and mouse natural killer cell inhibitory receptors recruit the PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 1996;151:4531-4534.
64. Thomas ML: Of ITAMs and ITIMs: Turning on and off the B cell antigen receptor. J Exp Med 1995;181:1953-1956.
65. Chen ZW, McAdam SN, Hughes AL, Dogon AL, Letvin NL, Watkins DI: Molecular cloning of orangutan and gibbon MHC class I cDNA: The HLA-A and -B loci diverged over 30 million years ago. J Immunol 1992;148:2547-2554.
66. Pohla H, Kuon W, Tabaczewski P, Doerner C, Weiss EH: Allelic variation in HLA-B and HLA-C sequences and the evolution of the HLA-B alleles. Immunogenetics 1989;29:297-307.
67. Cambiaggi A, Orengo AM, Meazza R, Sforzini S, Tazzari PL, Lauria F, Raspadori D, Zambello R, Semenzato G, Moretta L, Ferrini S: The natural killer-related receptor for HLA-C expressed on T cells from CD3 + lymphoproliferative disease of granular lymphocytes display either inhibitory or stimulatory function. Blood 1996;87:2369-2375.
68. Mingari MC, Cambiaggi MC, Vitale C, Schiavetti F, Bellomo R, Poggi A: Effect of superantigens on human thymocytes: Selective proliferation of Vβ2+ cells in response to the toxic shock syndrome toxin-1 and their deletion upon secondary stimulation. Int Immunol 1996;8:203-209.
69. Phillips JH, Gumberz JE, Parham P, Lamer LL: Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptor on T lymphocytes. Science 1995;128:403-405.
70. Mingari MC, Vitale C, Schiavetti F, Cambiaggi A, Bertone S, Zunino A, Ponte M: HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. Chem Immunol. Basel, Karger, 1996, vol 64, pp 135-145.